CHLA fever protocol

If < 1 y/o and T>39, get blood and urine cx.
If > 1 y/o and T>39.2?, get blood and urine cx.
Less than 1 month old and T>38: Admit for IV abx
1-2 m/o and T>38: Blood (CBC, Cx), Urine (Analysis, Cx), +/- CSF
Age 2-3 mos: gray zone to tap.
Age 2-12 and 7>39: Needs workup unless have prevnar. If had prevnar X 3, have 80% protection against bacteremia

2-24 months and T>39: Blood (CBC, Cx)
2-24 months and T>38: Consider urine if  2-6 mos circumcised, 2-12 mos uncirc, female
If WBC > 20 000, do CXR because 25% have pneumonia.

If < 6 mos and febrile seizure, then tap.
Most blood cultures grow out in 10 hours.

Random notes:

With stomatitis, varicella or another readily identified exanthem, the cause of the fever may be readily apparent on physical examination, and further diagnostic evaluation may not be required.3

A retrospective case series4 found that 32 percent of children two years of age and younger with meningitis had been given oral antibiotics for more than two days before the meningitis was detected. These children tended to be less ill-appearing, more commonly had upper respiratory findings and were less apt to manifest fever. Physicians must always bear in mind the possibility of partially treated meningitis when they are evaluating febrile infants and young children who have recently been prescribed antibiotics.

Day-care center attendance and frequent episodes of otitis media have been identified as risk factors for invasive pneumococcal infection in children younger than two years.5 Hence, infants and children with these risk factors may need to be evaluated more aggressively than those who do not attend day care.

A recent practice parameter on urinary tract infection recommended that urine be collected for culture by catheterization or suprapubic aspiration in all infants and children two months to two years of age with unexplained fever if empiric antibiotic treatment had been prescribed.10 Some authorities11 have suggested that a negative urinalysis on a bagged urine sample may be sufficient to eliminate the need for urine culture obtained by a more invasive technique. Other investigators12 have argued that microscopic urinalysis fails to detect 10 to 20 percent of urinary tract infections in infants and young children, and that culture of urine obtained by bladder catheterization is the only acceptable option.

A recent study13 found that 26 percent of children with fever and leukocytosis (a white blood cell count greater than 20,000 per mm3 [20 3 109 per L]) had pneumonia, even in the absence of respiratory symptoms.

The incidence of bacteremia does not differ significantly in febrile infants and young children with or without otitis media.14,15 Therefore, most authorities advise that otitis media not be considered a cause of fever and recommend that febrile infants and children with otitis media be evaluated for an occult infection.

Approximately 10 percent of well-appearing young infants with a temperature higher than 38°C (100.4°F) harbor a serious bacterial infection or meningitis.20-22 In contrast, fewer than 2 percent of well-appearing older infants and young children with a temperature higher than 39°C (102.2°F) manifest bacteremia.14,23

The authors of a commentary on the 1993 practice guideline argued that young children with fever should be carefully assessed for focal bacterial infection.11 If no focus is found and a child appears well, no tests other than urinalysis are routinely indicated, and antibiotics should not be given.

 

The following is from e-Medicine: Fever in the Toddler. Last Updated: October 1, 2004. http://www.emedicine.com/ped/topic3009.htm

Clinical and laboratory predictors are often used in trying to identify infants and children at risk for serious bacterial infection. Predictors used more frequently include (1) age of the patient, (2) presenting temperature, (3) absolute neutrophil count (ANC), (4) white blood cell (WBC) count, (5) absolute band count (ABC), and (6) the Yale Observation Scale. The first 3 predictors appear to be the most sensitive.

Stratifying infants into low- and high-risk groups is possible using a number of previously validated criteria. The most commonly used screening criteria are known as the Rochester criteria. To be categorized as low-risk using the Rochester criteria requires that the patient:

Newborns aged 0-28 days

The rate of bacteremia

Because the Rochester criteria are not routinely used to screen febrile infants for meningitis, the authors advocate performing a sepsis evaluation and hospitalizing the patient for parenteral antimicrobial therapy pending culture results. The sepsis workup includes complete blood cell (CBC) count, blood culture, urine analysis (UA), catheterized or suprapubic urine culture, cerebral spinal fluid (CSF) cell count, and CSF Gram stain and culture. If diarrhea is present, patients should have less than 5 WBCs/HPF in a Gram-stained smear of the stool. The risk of serious infections among the low-risk infants in this age group is very small. Jaskiewicz et al (1994) found the Rochester criteria to yield a negative predictive value of 99.3% for the detection of serious bacterial infection in children.

Similarly, Baraff et al (1992) found the risk of bacteremia to be about 1.1% and the risk of meningitis about 0.5% in patients classified as low-risk. However, most physicians perform a full sepsis workup (ie, CBC count, blood culture, UA, catheterized or suprapubic urine culture, CSF examination and culture) in all high- and low-risk infants in this age group, followed by hospitalization for parenteral antimicrobial therapy (eg, ampicillin/gentamicin or ampicillin/cefotaxime) pending culture results. No chest radiograph is necessary in the absence of respiratory symptoms or signs because the mean probability of finding an infiltrate on chest radiograph in asymptomatic infants is low.

High-risk newborns aged 4-8 weeks (29-56 d)

This includes both

As in the category of newborns aged 0-28 days, these infants deserve a full sepsis workup, followed by hospitalization for parental antimicrobials while waiting for culture results.

Low-risk newborns aged 4-8 weeks (29-56 d)

Febrile children aged 3-36 months
 

Summary of the Yale Observation Scale
Observation Items 1 (Normal) 3 (Moderate Impairment) 5 (Severe Impairment)
Quality of cry Strong with normal tone or contentment without crying Whimpering or sobbing Weak cry, moaning, or high-pitched cry
Reaction to parent stimulation Brief crying that stops or contentment without crying Intermittent crying Continual crying or limited response
 
Color Pink Acrocyanotic or pale extremities Pale or cyanotic or mottled or ashen
State variation If awake, stays awake; if asleep, wakes up quickly upon stimulation Eyes closed briefly while awake or awake with prolonged stimulation Falls asleep or will not arouse
 
Hydration Skin normal, eyes normal, and mucous membranes moist Skin and eyes normal and mouth slightly dry Skin doughy or tented, dry mucous membranes, and/or sunken eyes
Response (eg, talk, smile) to social overtures Smiling or alert (<2 mo) Briefly smiling or alert briefly (<2 mo) Unsmiling anxious face or dull, expressionless, or not alert (<2 mo)
 

Children with a total WBC count greater than 20,000/mL or an ANC of 12,000/mL or more carry a risk of occult bacteremia close to 20%. The bacteria most often isolated from the blood of children with bacteremia are Streptococcus pneumoniae (85-90%), Neisseria meningitidis, Streptococcus pyogenes, and Salmonella species.

The overall risk for children with bacteremia without antimicrobial therapy was quoted to be 21% for persistent bacteremia and 9% for meningitis. With the virtual elimination of Haemophilus influenzae because of routine immunization against this organism, current numbers are likely to be much lower than previously cited. In general, children in this age group with a temperature lower than 39°C should be assessed clinically. Laboratory tests or antibiotics are unnecessary if the child appears well.

Controversy exists about the management of the well-appearing child with temperatures higher than 39°C and no focus (or a minor upper respiratory focus) of infection. A meta-analysis conducted by Bulloch et al (1997) involving the use of empiric antibiotics in older infants and children with fever concluded that no significant outcome advantage exists for antibiotic therapy. The extravagant use of antibiotics may accelerate drug resistance, increase healthcare cost, and lead to development of partially treated meningitis.

A well-circulated practice guideline(1) for the management of this problem has recommended a CBC count, blood culture (see red highlight below on value of blood work), UA, and urine culture in girls younger than 2 years and boys younger than 6 months. According to those recommendations, children with WBC counts equal to or higher than 15,000/mL or an ANC higher than 10,000/mL should have blood cultures sent and receive ceftriaxone IM at a dose of 50 mg/kg as empiric therapy for possible occult bacteremia. Much of the controversy relating to the practice guideline involves the selection of this cutoff value. One set of investigators14 has advocated 18,000 white blood cells per mm3 (18 3 109 per L) as the cutoff value, arguing that use of this higher count is justified by the post-vaccination disappearance of H. influenzae infection and a lower overall prevalence of bacteremia than previously reported.

Reevaluate these patients in 18-24 hours and administer a second dose of ceftriaxone to provide antibiotic coverage until blood culture results have been negative for 48 hours. While most would concur that children should be screened for UTI, some maintain that the incidence of bacteremia and its complications has declined dramatically over the past decade; therefore, no blood work is necessary and only close outpatient follow-up is needed for these patients. With the introduction of the new heptavalent conjugate vaccine active against the most virulent pneumococcal serotypes, the incidence of bacteremia may decline further, providing additional support to this approach.

Factors most often associated with a failure to follow up include parental age younger than 21 years, lack of ownership of a car and parental perception of a lesser degree of illness in their child.19

Definitions of Terms in the 1993 Practice Guideline on the Management of Fever in Infants and Young Children
Term
Definition
Fever Rectal temperature of 38°C (100.4°F)*
Fever without source Acute febrile illness in which the etiology of the fever is not apparent after a careful history and physical examination
Serious bacterial infection Meningitis, sepsis, bone and joint infections, urinary tract infections, pneumonia, enteritis
Toxic appearance Clinical presentation characterized by lethargy, evidence of poor perfusion, cyanosis, hypoventilation or hyperventilation
Lethargy Poor or absent eye contact; failure of child to recognize parents or to interact with persons or objects in the environment


Hoberman A, Wald ER, Reynolds EA, et al: Pyuria and bacteriuria in urine specimens obtained by catheter from young children with fever. J Pediatr 1994 Apr; 124(4): 513-9

Jaskiewicz JA, McCarthy CA, Richardson AC, et al: Febrile infants at low risk for serious bacterial infection--an appraisal of the Rochester criteria and implications for management. Febrile Infant Collaborative Study Group. Pediatrics 1994 Sep; 94(3): 390-6

Baraff LJ, Oslund SA, Schriger DL, Stephen ML: Probability of bacterial infections in febrile infants less than three months of age: a meta-analysis. Pediatr Infect Dis J 1992 Apr; 11(4): 257-64

Bulloch B, Craig WR, Klassen TP: The use of antibiotics to prevent serious sequelae in children at risk for occult bacteremia: a meta-analysis. Acad Emerg Med 1997 Jul; 4(7): 679-83

Baraff LJ, Bass JW, Fleisher GR, Klein JO, McCracken GH, Powell KR, et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Pediatrics 1993; 92:1-12.

*Greenes DS, Harper MB. Low risk of bacteremia in febrile children with recognizable viral syndromes. Pediatr Infect Dis J 1999;18:258-61.

**Rothrock SG, Green SM, Wren J, Letai D, Daniel-Underwood L, Pillar E. Pediatric bacterial meningitis: is prior antibiotic therapy associated with an altered clinical presentation? Ann Emerg Med 1992;21:146-52.

***Takala AK, Jero J, Kela E, Ronnberg PR, Koskenniemi E, Eskola J. Risk factors for primary invasive pneumococcal disease among children in Finland. JAMA 1995;273:859-64.

  1. Baraff LJ, Bass JW, Fleisher GR, Klein JO, McCracken GH, Powell KR, et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Pediatrics 1993; 92:1-12.
  2. The septic appearing infant. In: Strange GR, Cooper A, et al., eds. APLS: the pediatric emergency course. American College of Emergency Physicians, American Academy of Pediatrics. 3d ed. Dallas: American College of Emergency Physicians, 1998:167-75.
  3. Greenes DS, Harper MB. Low risk of bacteremia in febrile children with recognizable viral syndromes. Pediatr Infect Dis J 1999;18:258-61.
  4. Rothrock SG, Green SM, Wren J, Letai D, Daniel-Underwood L, Pillar E. Pediatric bacterial meningitis: is prior antibiotic therapy associated with an altered clinical presentation? Ann Emerg Med 1992;21:146-52.
  5. Takala AK, Jero J, Kela E, Ronnberg PR, Koskenniemi E, Eskola J. Risk factors for primary invasive pneumococcal disease among children in Finland. JAMA 1995;273:859-64.
  6. Bauchner H, Philipp B, Dashefsky B, Klein JO. Prevalence of bacteriuria in febrile children. Pediatr Infect Dis J 1987;6:239-42.
  7. Crain EF, Gershel JC. Urinary tract infections in febrile infants younger than 8 weeks of age. Pediatrics 1990;86:363-7.
  8. Lin DS, Huang SH, Lin CC, Tung YC, Huang TT, Chiu NC, et al. Urinary tract infection in febrile infants younger than eight weeks of age. Pediatrics 2000;105:E20.
  9. Shaw KN, Gorelick M, McGowan KL, Yakscoe NM, Schwartz JS. Prevalence of urinary tract infection in febrile young children in the emergency department. Pediatrics 1998;102:e16.
  10. Practice parameter: the diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children. American Academy of Pediatrics. Committee on Quality Improvement. Subcommittee on Urinary Tract Infection. Pediatrics 1999;103(4 pt 1):843-52.
  11. Kramer MS, Shapiro ED. Management of the young febrile child: a commentary on recent practice guidelines. Pediatrics 1997;100:128-34.
  12. Baraff LJ, Schriger DL, Bass JW, Fleisher GR, Klein JO, McCracken GH, et al. Management of the young febrile child. Commentary on practice guidelines. Pediatrics 1997;100:134-6.
  13. Bachur R, Perry H, Harper MB. Occult pneumonias: empiric chest radiographs in febrile children with leukocytosis. Ann Emerg Med 1999;33:166-73.
  14. Lee GM, Harper MB. Risk of bacteremia for febrile young children in the post-Haemophilus influenzae type b era. Arch Pediatr Adolesc Med 1998;152: 624-8.
  15. Schutzman SA, Petrycki S, Fleisher GR. Bacteremia with otitis media. Pediatrics 1991;87:48-53.
  16. Oppenheim PI, Sotiropoulos G, Baraff LJ. Incorporating patient preferences into practice guidelines: management of children with fever without source. Ann Emerg Med 1994;24:836-41.
  17. Kramer MS, Etezadi-Amoli J, Ciampi A, Tange SM, Drummond KN, Mills EL, et al. Parents' versus physicians' values for clinical outcomes in young febrile children. Pediatrics 1994;93:697-702.
  18. Wittler RR, Cain KK, Bass JW. A survey about management of febrile children without source by primary care physicians. Pediatr Infect Dis J 1998;17:271-7.
  19. Scarfone RJ, Joffe MD, Wiley JF, Loiselle JM, Cook RT. Noncompliance with scheduled revisits to a pediatric emergency department. Arch Pediatr Adolesc Med 1996;150:948-53.
  20. Baskin MN. The prevalence of serious bacterial infections by age in febrile infants during the first 3 months of life. Pediatr Ann 1993;22:462-6.
  21. Jaskiewicz JA, McCarthy CA, Richardson AC, White KC, Fisher DJ, Dagan R, et al. Febrile infants at low risk for serious bacterial infection--an appraisal of the Rochester criteria and implications for management. Febrile Infant Collaborative Study Group. Pediatrics 1994;94:390-6.
  22. Chiu CH, Lin TY, Bullard MJ. Identification of febrile neonates unlikely to have bacterial infections. Pediatr Infect Dis J 1997;16:59-63.
  23. Alpern ER, Alessandrini EA, Bell LM, Shaw KN, McGowan KL. Occult bacteremia from a pediatric emergency department: current prevalence, time to detection, and outcome. Pediatrics 2000;106: 505-11.
  24. Baker MD, Bell LM. Unpredictability of serious bacterial illness in febrile infants from birth to 1 month of age. Arch Pediatr Adolesc Med 1999;153:508-11.
  25. Kadish HA, Loveridge B, Tobey J, Bolte RG, Corneli HM. Applying outpatient protocols in febrile infants 1-28 days of age: can the threshold be lowered? Clin Pediatr [Phila] 2000;39:81-8.
  26. Baker MD, Bell LM, Avner JR. The efficacy of routine outpatient management without antibiotics of fever in selected infants. Pediatrics 1999;103:627-31.
  27. Rothrock SG, Harper MB, Green SM, Clark MC, Bachur R, McIlmail DP, et al. Do oral antibiotics prevent meningitis and serious bacterial infections in children with Streptococcus pneumoniae occult bacteremia? A meta-analysis. Pediatrics 1997;99:438-44.
  28. Baraff LJ, Oslund S, Prather M. Effect of antibiotic therapy and etiologic microorganism on the risk of bacterial meningitis in children with occult bacteremia. Pediatrics 1993;92:140-3.
  29. Baker RC, Tiller T, Bausher JC, Bellet PS, Cotton WH, Finley AH, et al. Severity of disease correlated with fever reduction in febrile infants. Pediatrics 1989;83:1016-9.
  30. Bulloch B, Craig WR, Klassen TP. The use of antibiotics to prevent serious sequelae in children at risk for occult bacteremia: a meta-analysis. Acad Emerg Med 1997;4:679-83.
  31. Rothrock SG, Green SM, Harper MB, Clark MC, McIlmail DP, Bachur R. Parenteral vs oral antibiotics in the prevention of serious bacterial infections in children with Streptococcus pneumoniae occult bacteremia: a meta-analysis. Acad Emerg Med 1998;5:599-606.
  32. Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 2000;19:187-95.
  33. Shinefield HR, Black S. Efficacy of pneumococcal conjugate vaccines in large scale field trials. Pediatr Infect Dis J 2000;19:394-7.
  34. Baraff LJ. Management of fever without source in infants and children. Ann Emerg Med 2000;36: 602-14.